Recombinant hirudin (Kerun Biopharmaceutical)

Product Name :
Recombinant hirudin (Kerun Biopharmaceutical)

Search keywords :
Hirudin

drugId :
null

Target Vo:
Prothrombin

Target Vo Short Name :
PT

Moa_Name:
Prothrombin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Chongqing Kerun Biologic Pharmaceutical Development Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Thrombosis

Termination Status :
IND

China Termination Status :
IND

Highest Status:
Discontinued

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GPX4 Antibody
PERK Antibody
phospho-ERK1 + 2 (Thr183/Tyr185) Antibody: phospho-ERK1 + 2 (Thr183/Tyr185) Antibody is an unconjugated, approximately 42/44 kDa, rabbit-derived, anti-phospho-ERK1 + 2 (Thr183/Tyr185) polyclonal antibody. phospho-ERK1 + 2 (Thr183/Tyr185) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, cow, horse, rabbit, guinea pig background without labeling.

Author: Betaine hydrochloride

Related Posts